INDOKEM logo

Indokem Limited

INDOKEM·BSE·
₹715.00▲ +10.00 (+1.42%)
Market Cap2033.05 Cr
PE Ratio1067.16
Volume4,241
Day High - Low790.00 - 715.00
52W High-Low790.00 - 555.00

Indokem Limited (INDOKEM): company summary

The company's annual revenue fell 4.9% to ₹169 crore, while net profit dropped 41.1% to ₹2 crore.

Indokem Limited (INDOKEM) is a micro-cap Chemicals company valued at ₹2,033 crore operating in Specialty Chemicals on the NSE and BSE.

Recent price move
Indokem Limited last traded at ₹715, modestly up 1.42% on the day.
Recent developments
On 2026-06-30, the company reported a net profit of ₹1 crore for the latest quarter, up from ₹1 crore in the same quarter a year earlier, showing stability in profitability. The company's promoter holding remained at 68.67%, with no significant changes in foreign or domestic institutional holdings.
Financial performance
The company's annual revenue fell 4.9% to ₹169 crore, while net profit dropped 41.1% to ₹2 crore. The latest quarter saw revenue rise 12.2% year-on-year to ₹47 crore, and net profit surged 52.9% to ₹1 crore, indicating improved performance in the most recent period.
Valuation multiples
The stock trades at 1067.2 times earnings, 36.72 times book value.
Things to watch
The company's net profit margin narrowed to 1.1% from 1.8% in the prior year, reflecting pressure on profitability. The stock is 3.0% below its 52-week high, and net profit fell 41.1% annually, indicating challenges in maintaining earnings growth.
Where it stands
Indokem Limited ended the latest quarter with a net profit of ₹1 crore, up 52.9% from the same quarter a year earlier, while annual net profit fell 41.1% to ₹2 crore. The stock is 3.0% below its 52-week high, and the net profit margin has declined to 1.1%.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
2.5/10
Poor
Fair Value
Sign in to see
ROE
2.90%
Weak
P/E
1067.16x
Expensive
Debt / Equity
0.42
Moderate
Industry
Chemicals
Specialty Chemicals
Overall View
Mixed

Price performance

Day₹715.00
₹790.00
52W₹555.00
₹790.00
DocStoX take

Supported by growth (7.5) and momentum (7.5), but held back by valuation (0.0). Growth looks strong at 7.5, but that is offset by valuation at 0.0 and quality at 0.3. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
2.5
/10
Poor
Quality
Weak
ROE 2.9%
Valuation
Expensive
P/E 200.0×
Growth
Strong
Revenue +26.6% 5Y CAGR
Risk
Elevated
D/E 0.42
Momentum
Strong
68% of 52-week range

At a glance

Market Cap
₹2,033 Cr
52W High / Low
₹790 / ₹555
Dividend Yield
0.00%
Promoter Holding
68.58%
EPS (TTM)
₹0.67
Book Value
₹23.12

Key highlights

  • Revenue compounding 27% a year
  • Loss-making in some of the last 5 years
  • Quality is weak (0.3/10)
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Chemicals stocks · Specialty Chemicals

Indokem Limited peers in Chemicals

Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.